Brief: Mayne Pharma Updates On Status Of FIRB Approval & Second Court Hearing
20/11/2025 07:49
Nov 20 (Reuters) - Mayne Pharma Group Ltd MYX.AX: UPDATE ON STATUS OF FIRB APPROVAL AND SECOND COURT HEARING FIRB EXTENDS DEADLINE FOR APPROVAL TO 21 NOVEMBER 2025 SHARES TO BE SUSPENDED FROM TRADING ON NOV 24 COURT HEARING RESCHEDULED TO 23 NOV Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)